NP Thyroid 60 (Page 2 of 2)

HOW SUPPLIED

Product: 53002-1029

NDC: 53002-1029-3 30 TABLET in a BOTTLE

NDC: 53002-1029-0 100 TABLET in a BOTTLE

Store in a tight container protected from light and moisture. Store between 15° — 30°C (59° — 86°F).

All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. Please note: this is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or other equivalency testing. No representation is made as to generic status or bioequivalency. Each person recommending a prescription substitution using this product shall make such recommendations based on each such person’s professional opinion and knowledge, upon evaluating the active ingredients, excipients, inactive ingredients and chemical information provided herein.

NP Thyroid 1 Grain (60mg) Tablets, USP

Label Image
(click image for full-size original)
NP THYROID 60 levothyroxine, liothyronine tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:53002-1029(NDC:42192-330)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE (LEVOTHYROXINE) LEVOTHYROXINE 38 ug
LIOTHYRONINE (LIOTHYRONINE) LIOTHYRONINE 9 ug
Inactive Ingredients
Ingredient Name Strength
CALCIUM STEARATE
DEXTROSE MONOHYDRATE
MALTODEXTRIN
MINERAL OIL
Product Characteristics
Color brown (BROWN) Score no score
Shape ROUND Size 6mm
Flavor Imprint Code AP;330
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:53002-1029-3 30 TABLET in 1 BOTTLE None
2 NDC:53002-1029-0 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 11/11/2010
Labeler — RPK Pharmaceuticals, Inc. (147096275)
Establishment
Name Address ID/FEI Operations
RPK Pharmaceuticals, Inc. 147096275 RELABEL (53002-1029), REPACK (53002-1029)

Revised: 12/2020 RPK Pharmaceuticals, Inc.

Page 2 of 2 1 2

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.